San Diego life science companies raised just $1.4 billion through the third quarter, their weakest nine months since 2022, as Savills' Q3 2026...
ByThe RegistryOctober 15, 2026 
Signup for news and special announcements!
You have successfully joined our subscriber list.
Error: Contact form not found.